People · Operator
Named in public records as an officer, director or promoter · active 2019–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Omniseq, Inc. | — | Biotechnology | Series A | $18.9M | $56.7M | 2019 |
Paul Buford Billings at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Paul Buford Billings on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Gardner | 1 | 2 |
| Carl Morrison | 1 | 1 |
| Margot Schoenborn | 1 | 1 |
| R. Buford Sears | 1 | 1 |
| Marcia Buford Eisenberg | 1 | 1 |
| Kenneth Buford Manning | 1 | 1 |
| Steven Buford Anderson | 1 | 1 |
| Mark Garner | 1 | 1 |
| KENNETH A. MANNING | 1 | 1 |
| CANDACE JOHNSON | 1 | 1 |
| MARCIA A. EISENBERG | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.